Serum chromogranin A concentration in hyperthyroidism before and after medical treatment

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 7, 2009, Pages 2321-2324

  Al Shoumer, Kamal A S ^a   Vasanthy, Bagavathy A ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBIMAZOLE; CHROMOGRANIN A; GLUCOSE; INSULIN; LIOTHYRONINE; PROINSULIN; PROPRANOLOL; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ACTIVITY; DISEASE MARKER; EUTHYROIDISM; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GRAVES DISEASE; HORMONE BLOOD LEVEL; HUMAN; HYPERTHYROIDISM; INSULIN RESISTANCE; KIDNEY FUNCTION TEST; LIOTHYRONINE BLOOD LEVEL; LIVER FUNCTION TEST; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THYROID FUNCTION; THYROID FUNCTION TEST; THYROXINE BLOOD LEVEL; TREATMENT DURATION;

EID: 67650260846     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2231     Document Type: Article

References (20)

1. Deftos LJ 1991 Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr Rev 12:181-187
2. O'Connor DT, Deftos LJ 1986 Secretion of chromogranin A by peptide producing endocrine neoplasms. N Engl J Med 314:1145-1151
3. Nobels FR, Kwekkeboom DJ, Bouillon R, Lamberts SW 1998 Chromogranin A: its clinical value as marker of neuroendocrine tumors. Eur J Clin Invest 28:431-440
4. Dimsdale JE, O'Connor D, Ziegler M, Mills P 1989 Does chromogranin A respond to short-term mild physiologic challenge? Neuropsychopharmacology 2:237-240
5. Takiyyuddin MA, Cervenka JH, Sullivan PA, Pandian MR, Parmer RJ, Barbosa JA, O'Connor DT 1990 Is physiologic sympathoadrenal catecholamine release exocytotic in humans? Circulation 81:185-195
6. Takiyyuddin MA, Brown MR, Dinh TQ, Cervenka JH, Braun SD, Parmer RJ, Kennedy B, O'Connor DT 1994 Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release. J Auton Pharmacol 14:187-200
7. Eriksson B, Arnberg H, Oberg K, Hellman U, Lundqvist G, Wernstedt C, Wilander E 1990 A polyclonal antiserum against chromogranin A and B: a new sensitive marker for neuroendocrine tumours. Acta Endocrinol (Copenh) 122:145-155
8. Eriksson B, Oberg K 1991 Peptide hormones as tumor markers in neuroendocrine gastrointestinal tumors. Acta Oncol 30:477-483
9. O'Connor DT, Pandlan MR, Carlton E, Cervenka JH, Hslao RJ 1989 Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure. Clin Chem 35:1631-1637
10. Stridsberg M, Husebye ES 1997 Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma. Eur J Endocrinol 136:67-73
11. Takiyyuddin MA, Cervenka JH, Hsiao RJ, Barbosa JA, Parmer RJ, O'Connor DT1990 Chromogranin A. Storage and release in hypertension. Hypertension 15:237-246
12. Borch K, Stridsberg M, Burman P, Rehfeld JF 1997 Basal chromograninA and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis. Scand J Gastroenterol 32:198-202
13. Kadmon D, Thompson TC, Lynch GR, Scardino PT 1991 Elevated plasma chromogranin-A concentrations in prostatic carcinoma. J Urol 146:358-361
14. Nanes MS, O'Connor DT, Marx SJ 1989 Plasma chromogranin A in primary hyperparathyroidism. J Clin Endocrinol Metab 69:950-955
15. Burggraaf J, Tulen JH, Lalezari S, Schoemaker RC, De Meyer PH, Meinders AE, Cohen AF, Pijl H 2001 Sympathovagal imbalance in hyperthyroidism. Am J Physiol Endocrinol Metab 281:E190-E195
16. Chen JL, Chiu HW, Tseng YJ, Chu WC 2006 Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability. Clin Endocrinol (Oxf) 64:611-616
17. Eustatia-Rutten CF, Corssmit EP, Heemstra KA, Smit JW, Schoemaker RC, Romijn JA, Burggraaf J 2008 Autonomic nervous system function in chronic exogenous subclinical thyrotoxicosis and the effect of restoring euthyroidism. J Clin Endocrinol Metab 93:2835-2841
18. Taniyama M, Kitamura K, Ban Y, Sugita E, Ito K, Katagiri T 1997 Elevation of circulating proadrenomedullin-N terminal 20-peptide in thyrotoxicosis. Clin Endocrinol (Oxf) 46:271-274
19. Nehar D, Lombard-Bohas C, Oliveri S, Claustrat B, Chayvialle J-A, Penes M-C, Sassolas G, Borson-Chazot F 2004 Interest of chromogranin A for diagnosis and follow up of endocrine tumours. Clin Endocrinol (Oxf) 60:644-652
20. Polikar R, Kennedy B, Ziegler M, O'Connor DT, Smith J, Nicod P 1990 Plasma norepinephrine kinetics, dopamine-α-hydroxylase, and chromogranin A in hypothyroid patients before and following replacement therapy. J Clin Endocrinol Metab 70:277-281